As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/6/21  Bristol-Myers Squibb Co.          8-K:5,9      5/4/21   11:248K                                   Broadridge Fin’l So… Inc 
  5/4/21  Bristol-Myers Squibb Co.          S-8          5/4/21    3:81K                                    Broadridge Fin’l So… Inc 
  5/4/21  Bristol-Myers Squibb Co.          S-8 POS      5/4/21    3:85K                                    Broadridge Fin’l So… Inc 
  5/4/21  Bristol-Myers Squibb Co.          8-K:5,9      5/4/21   18:2.1M                                   Broadridge Fin’l So… Inc 
 3/25/21  Bristol-Myers Squibb Co.          DEF 14A      5/4/21    1:9.7M                                   Broadridge Fin’l So… Inc 
 3/12/21  Bristol-Myers Squibb Co.          PRE 14A      5/4/21    1:9.6M                                   Broadridge Fin’l So… Inc 

____________
¹	Filing/Form Types:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	PRE 14A	Preliminary Proxy Statement — Schedule 14A.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
	S-8 POS	Post-Effective Amendment of a Form S-8 Registration.